H3D webinar on Advancements in Antimalarial Drug Discovery & Development
The University of Cape Town’s Holistic Drug Discovery and Development (H3D) Centre is pleased invite you to the webinar on Advancements in Antimalarial Drug Discovery & Development hosted by Collaborative Drug Discovery (CDD).
Date: 26th of June, 2025
Time: 8:00 AM PT | 11:00 AM ET | 4:00 PM CET
This webinar will present current methodologies and recent innovations in antimalarial drug discovery. Participants will gain insights into state-of-the-art screening approaches, novel compound development, and strategic pathways for advancing candidates through the drug development pipeline. The session will feature analyses of therapeutic efficacy, mechanistic insights into parasite resistance, and approaches to optimization of pharmacokinetic parameters.
Bringing together leading experts from preeminent research institutions focused on antimalarial drug discovery. The event features representatives from four key organizations at the forefront of global malaria research and eradication efforts:
- Gates Foundation – Major funder and coordinator of global malaria eradication initiatives
- Medicines for Malaria Venture (MMV) – A leading product development partnership in antimalarial drug research
- University of Cape Town (UCT) – Site of Africa’s premier drug discovery hub focused on diseases affecting the continent
- University of California San Diego (UCSD) – Home to cutting-edge malaria parasite biology and drug screening platforms
Key Learning Objectives:
- Comparative analysis of phenotypic versus target-based screening approaches
- Structure-activity relationship optimization in antimalarial compound development
- Molecular mechanisms of action for next-generation antimalarials
- Strategic approaches to drug resistance mitigation.
Click here to register
